CBS and central nervous system cancer: Enhanced glioma tumorigenicity upon CBS loss was associated with upregulation of HIF-2α protein level and HIF-2α-dependent transcriptional activation of angiopoietin like 4 (ANGPTL4) and vascular endothelial growth factor A (VEGFA).